GeneralConnection.com ➔ Dictionary
Dictionary Search

tardive

Synonyms

Adjective

1. late

Usage
Musician Carnie Wilson Talks Tardive Dyskinesia (TD): Signs, Stigma, and Getting Diagnosed - FOX Carolina News
A Novel Dental Screening Scale for Tardive Dyskinesia Aims to Improve Detection - Pharmacy Practice News
Managing Tardive Dyskinesia (Part 6) - Specialty Pharmacy Continuum
Living with Tardive Dyskinesia - Brain & Life
Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of INGREZZA® (valbenazine) Capsules Across a Broad Range of Patients - PR Newswire
Diagnostic Challenges in Distinguishing Huntington Disease From Tardive Dyskinesia - Psychiatrist.com
Patients With Tardive Dyskinesia Symptoms May Go Undiagnosed - MedPage Today
Tardive Dyskinesia in Older Adults: Identification and Management in Long-Term Care Settings - Psychiatric Times
Tardive Dyskinesia: 11 Tips to Feel More in Control of Uncontrollable Movements - Everyday Health
Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment - PR Newswire
Measuring What Matters: Further Validation for the Tardive Dyskinesia Impact Scale, a Novel Patient-Reported Outcome Measure in Valbenazine Clinical Trials - Psychiatrist.com
CMS Moves to Close the Tardive Dyskinesia Screening Gap - Pharmacy Practice News
AI Screening Tool for Tardive Dyskinesia Identifies Disorder and Prompts Clinical Evaluation - Psychiatric Times
Tardive Dyskinesia Pharmacy Medication Safety Neurology - Specialty Pharmacy Continuum
Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities - PR Newswire
The Patient Perspective on Tardive Dyskinesia - Psychiatrist.com
Tardive Dyskinesia in Children and Adolescents: Uncommon, but Not Absent - Pharmacy Practice News
Managing Tardive Dyskinesia (Part 2) - Specialty Pharmacy Continuum
Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules - PR Newswire
Managing Tardive Dyskinesia: Drug-Induced Risks and Therapeutic Advances - Specialty Pharmacy Continuum
First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings - Psychiatric Times
Spotlight on the Psychosocial Impact of Tardive Dyskinesia - Psychiatry Advisor
Risk of Tardive Dyskinesia Higher in Women - MedPage Today
New Data From IMPACT-TD Registry: Only 23% of Young Adults With Mood Disorders and Tardive Dyskinesia Symptoms Are Formally Diagnosed - Psychiatric Times
How to Talk About Tardive Dyskinesia with A Doctor - Healthgrades
First Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings - Pharmacy Practice News
Masking and Unmasking in Tardive Dyskinesia - Pharmacy Practice News
Why Mild Tardive Dyskinesia Is Often the Hardest To Manage - Pharmacy Practice News
Building a Tardive Dyskinesia Center of Excellence: A Multidisciplinary Model - Pharmacy Practice News
Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders - Pharmacy Practice News
Dental Complications Tardive Dyskinesia Care Insights - Pharmacy Practice News
Experts develop treatment recommendations for tardive dyskinesia among nursing home residents - McKnight's Long-Term Care News
Ask the Advocate: How Can I Cope with the Stigma of Tardive Dyskinesia? - Healthline
A Look At Teva (TEVA) Valuation After New Real World Tardive Dyskinesia Data Release - Yahoo Finance
The Polypharmacy Challenge in Tardive Dyskinesia - Pharmacy Practice News
Seen but Unseen: Tardive Dyskinesia in Long-Term Care - Pharmacy Practice News
Phase 2 Study Initiated for NBI-1065890 to Treat Tardive Dyskinesia - Psychiatric Times
Pharmacists Can Help Close The Tardive Dyskinesia Dx Gap - Pharmacy Practice News
Assessing Tardive Dyskinesia: AIMS and the Clinician’s Tardive Inventory - Pharmacy Practice News
Medicare Policy Expansion: Implications for Patients With Tardive Dyskinesia - Clinical Advisor
Tardive Dyskinesia Burden Perspectives from Physicians and Patients - Pharmacy Practice News
How VMAT2 Inhibitors Are Reshaping Tardive Dyskinesia Care - Pharmacy Practice News
VMAT2 Inhibitors for Tardive Dyskinesia: What Psychiatrists Should Know | Focus - Psychiatry Online
Most Tardive Dyskinesia Cases Go Undiagnosed, Real-World Study Finds - Pharmacy Practice News
New Review on VMAT2 Inhibitors and Ingrezza for Treatment of Tardive Dyskinesia - Psychiatric Times
Accurate Diagnosis of Tardive Dyskinesia Is Critical to Optimal Outcomes - Pharmacy Practice News
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia - PR Newswire
How to Cope With Tardive Dyskinesia Stigma: 6 Tips - Everyday Health
Tardive Dyskinesia's Impact on Quality of Life - MedPage Today
Phase 4 Data Support Effectiveness of Deutetrabenazine in Managing Tardive Dyskinesia, Chorea - NeurologyLive
Decreased N-acetylaspartate plus N-acetyl-aspartyl-glutamate levels in the caudate of schizophrenia patients with tardive dyskinesia - Nature
Valbenazine Linked to Better Physical and Emotional Well-Being in Tardive Dyskinesia - NeurologyLive
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia Severity - Psychiatric Times
AI Eyes on TD: Could Video-Based Detection Shrink the Diagnosis Gap? - Pharmacy Practice News
EMA Says Active Substance in Tardive Dyskinesia Drug Not New - Medscape
Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care - Yahoo Finance
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms - Psychiatric Times
VMAT2 Inhibitor Tardive Dyskinesia Treatment Complexity - Pharmacy Practice News
Tardive Dyskinesia Management Gaps in LongTerm Care - Pharmacy Practice News
New Post-Hoc Analysis: Treatment With Ingrezza Results in Earlier Remission of Tardive Dyskinesia Symptoms and Reduced Disease Burden - Psychiatric Times
Neurocrine cites work disruption data to make case for timely movement disorder diagnosis - Fierce Pharma
Neuroleptic Malignant Syndrome Unmasked: A Case of Extrapyramidal Syndrome With Tardive Dystonia Leading to a Life-Threatening Crisis - Cureus
This condition affects at least 5% of people who take antipsychotic medication - Health: Trusted and Empathetic Health and Wellness Information
Neurocrine presents data on tardive dyskinesia treatment - Investing.com
Real-world data shows AUSTEDO improves life for patients with tardive dyskinesia - PharmaTimes
Mitigating the Risk For Tardive Dyskinesia in Elderly Patients on Antipsychotics - MedPage Today
Patient Awareness of Tardive Dyskinesia: Insights From Cherian Karunapuzha, MD - Psychiatric Times
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR - PR Newswire
LUYE PHARMA (02186.HK) Innovative Drug LY03015 Achieves Positive Results in Clinical Study for Tardive Dyskinesia - AASTOCKS.com
Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden - PR Newswire
9 Questions to Ask Your Doctor About Taking VMAT2 Inhibitors for TD - HealthCentral
Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis - Yahoo Finance
Acute exacerbation of major depressive disorder following valbenazine treatment for tardive dyskinesia: A case report - Wiley Online Library
Teva Pharmaceuticals Reports Positive New Data on AUSTEDO and AUSTEDO XR for Tardive Dyskinesia Management at Psych Congress Elevate - Quiver Quantitative
Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive - Fierce Pharma
Digital Tools to Detect Tardive Dyskinesia - MedPage Today
Assessing Neurocrine Biosciences (NBIX) Valuation After New Phase 2 VMAT2 Tardive Dyskinesia Trial Launch - Yahoo Finance
Navigating Treatment for Huntington's Disease (Part 7) - Pharmacy Practice News
VIDEO: Using the ‘gold standard’ assessment for tardive dyskinesia diagnosis - Healio
'Mild' TD still affects daily life; new data track treatment gains - Stock Titan
Teva reports diagnostic gap in tardive dyskinesia patients - Investing.com
VMAT-2 Inhibitor Differences and Dosing in Tardive Dyskinesia - HMP Global Learning Network
New data support early use of Ingrezza in mild tardive dyskinesia - The Pharma Letter
Doctors report TD reductions, better speech and socializing with INGREZZA - Stock Titan
Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice - Pharmacy Times
Deep Brain Stimulation for Tardive Dyskinesia - MedPage Today
Teva Pharmaceuticals Highlights Diagnostic Gaps in Tardive Dyskinesia Impacting Patients with Mood Disorders, According to New IMPACT-TD Registry Analysis - Quiver Quantitative
Drug for uncontrollable movements eased symptoms in 94% of patients over 48 weeks - Stock Titan
Clinical practice guidelines for the treatment of tardive dyskinesia in Europe: A descriptive review - Cambridge University Press & Assessment
Neurocrine Biosciences begins Phase II NBI-1065890 trial for TD - Clinical Trials Arena
What’s New in Tardive Dyskinesia, With Jonathan Meyer, MD - HCPLive
Well-Rounded Examination for Treatment of Tardive Dyskinesia - Psychiatric Times
How Investors Are Reacting To Teva (TEVA) AUSTEDO Real‑World Data On Tardive Dyskinesia Improvement - simplywall.st
When Movement Isn’t the Primary Problem: Reframing Treatment Priorities in Early Huntington’s Disease - Pharmacy Practice News
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR - PR Newswire
Assessing Teva (NYSE:TEVA) Valuation After New IMPACT-TD Registry Findings On Tardive Dyskinesia - Sahm
Teva Study Finds Only 23% of Younger Adults with Mood - GlobeNewswire
VIDEO: Tardive dyskinesia can ‘pretty significantly’ impact patients’ quality of life - Healio
Haloperidol Induced Orofacial Dyskinesia: Clinical Insights Into Buccolingual Masticatory Syndrome - Wiley Online Library
tDCS Improves Tardive Dyskinesia Symptoms 50% vs Sham - Physician's Weekly
Foreign Language Equivalents
Foreign Language Equivalents of 'tardive'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
tarduve,   tardivee,   tardove,   yardive,   tadrive,   tardiive,   tardivr,   tardiv,   tardie,   rardive,   tardibe,   tardivve,   tardiev,   tardice,   tardvie,   tarsive,   tarive,   ttardive,   trdive,   tardivw,   tadive,   tardve,   taardive,   ardive,   tarfive,   tradive,   taridve,   atrdive,   tatdive,   tsrdive,   taedive,   tarrdive,   tarddive
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z